HUP0300326A2 - Vírusellenes hatású 4-oxo-1,4-dihidro-3-cinnolinkarboxamid-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Vírusellenes hatású 4-oxo-1,4-dihidro-3-cinnolinkarboxamid-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0300326A2 HUP0300326A2 HU0300326A HUP0300326A HUP0300326A2 HU P0300326 A2 HUP0300326 A2 HU P0300326A2 HU 0300326 A HU0300326 A HU 0300326A HU P0300326 A HUP0300326 A HU P0300326A HU P0300326 A2 HUP0300326 A2 HU P0300326A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkyl
- general formula
- atom
- compounds
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- IJAVOENDLHVSER-UHFFFAOYSA-N 4-oxo-1h-cinnoline-3-carboxamide Chemical class C1=CC=CC2=C(O)C(C(=O)N)=NN=C21 IJAVOENDLHVSER-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány az (I) általános képletű vegyületekre vonatkozik, aképletben A jelentése klór-, brómatom, ciano-, nitrocsoport vagyfluoratom; R1 jelentése R5 vagy -SO2R9 általános képletű csoport; R2,R3 és R4 jelentése azonosan vagy különbözően hidrogénatom,halogénatom, arilcsclport, -S(O)mR6, -(C=O)R6, -(C=O)OR9 általánosképletű csoport, cianocsoport, heterociklus, amely heterociklus egyszánatomon keresztül kapcsolódik, -OR10 általános képletű csoport, -OHet, -NR7R8, -SR10, -Shet, -NHCOR12, -NHSO2R12 általános képletűcsoport, alkilcsoport, amely részben telítetlen lehet, és adottesetben egy vagy több szubsztituenssel, mégpedig R11, -OR13, -SR10, -SR13, -NR7R8 általános képletű csoporttal, halogénatommal, -(C=O)-alkil- vagy, -SOmR9 általános képletű csoporttal helyettesített, R5adott esetben helyettesített alkil- vagy cikloalkilcsoport, R9előnyösen aril-, heteroaril-, alkil- vagy cikloalkilcsoport. Atalálmány kiterjed a fenti vegyületeket tartalmazó vírusellenes hatásúgyógyszerkészítményekre és a vegyületek alkalmazási eljárására is. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19129100P | 2000-03-21 | 2000-03-21 | |
PCT/US2001/005811 WO2001070706A2 (en) | 2000-03-21 | 2001-03-15 | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0300326A2 true HUP0300326A2 (hu) | 2003-07-28 |
HUP0300326A3 HUP0300326A3 (en) | 2003-09-29 |
Family
ID=22704885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300326A HUP0300326A3 (en) | 2000-03-21 | 2001-03-15 | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides of antiviral effect their use and pharmaceutical compositions containing them |
Country Status (28)
Country | Link |
---|---|
US (1) | US6624160B2 (hu) |
EP (1) | EP1265873B1 (hu) |
JP (1) | JP2003528087A (hu) |
KR (1) | KR20020081479A (hu) |
CN (1) | CN1406228A (hu) |
AR (1) | AR027978A1 (hu) |
AT (1) | ATE252086T1 (hu) |
AU (1) | AU2001247224A1 (hu) |
BR (1) | BR0109487A (hu) |
CA (1) | CA2400000A1 (hu) |
CZ (1) | CZ20023141A3 (hu) |
DE (1) | DE60100999T2 (hu) |
DK (1) | DK1265873T3 (hu) |
EA (1) | EA200201002A1 (hu) |
EE (1) | EE200200541A (hu) |
ES (1) | ES2208581T3 (hu) |
HK (1) | HK1052694A1 (hu) |
HU (1) | HUP0300326A3 (hu) |
IL (1) | IL151787A0 (hu) |
MX (1) | MXPA02009251A (hu) |
NO (1) | NO20024502L (hu) |
NZ (1) | NZ521524A (hu) |
PL (1) | PL357443A1 (hu) |
PT (1) | PT1265873E (hu) |
SI (1) | SI1265873T1 (hu) |
SK (1) | SK12102002A3 (hu) |
WO (1) | WO2001070706A2 (hu) |
ZA (1) | ZA200207540B (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20011349A1 (es) * | 2000-06-16 | 2002-01-19 | Upjohn Co | 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales |
WO2014070976A1 (en) * | 2012-11-03 | 2014-05-08 | Boehringer Ingelheim International Gmbh | Inhibitors of cytomegalovirus |
KR20230170813A (ko) | 2018-09-12 | 2023-12-19 | 노파르티스 아게 | 항바이러스 피리도피라진디온 화합물 |
US11667613B2 (en) | 2019-09-26 | 2023-06-06 | Novartis Ag | Antiviral pyrazolopyridinone compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8513639D0 (en) | 1985-05-30 | 1985-07-03 | Ici America Inc | Cinnoline compounds |
GB8702288D0 (en) * | 1987-02-02 | 1987-03-11 | Erba Farmitalia | Cinnoline-carboxamides |
ATE239477T1 (de) | 1995-08-02 | 2003-05-15 | Darwin Discovery Ltd | Chinolone und deren therapeutische verwendung |
CA2225555A1 (en) | 1995-08-02 | 1997-02-13 | Chiroscience Limited | Quinolones and their therapeutic use |
NZ505362A (en) | 1997-12-22 | 2004-12-24 | Upjohn Co | 4-hydroxyquinoline-3-carboxamides and -hydrazides useful as antiviral agents |
WO1999038867A1 (fr) | 1998-01-29 | 1999-08-05 | Suntory Limited | Derives de 1-cycloalkyle-1,8-naphthyridine-4-one presentant une activite inhibitrice de la phosphodiesterase iv |
-
2001
- 2001-03-15 EP EP01920138A patent/EP1265873B1/en not_active Expired - Lifetime
- 2001-03-15 ES ES01920138T patent/ES2208581T3/es not_active Expired - Lifetime
- 2001-03-15 CN CN01805756A patent/CN1406228A/zh active Pending
- 2001-03-15 BR BR0109487-4A patent/BR0109487A/pt not_active IP Right Cessation
- 2001-03-15 DK DK01920138T patent/DK1265873T3/da active
- 2001-03-15 HU HU0300326A patent/HUP0300326A3/hu unknown
- 2001-03-15 CZ CZ20023141A patent/CZ20023141A3/cs unknown
- 2001-03-15 PL PL01357443A patent/PL357443A1/xx not_active Application Discontinuation
- 2001-03-15 SK SK1210-2002A patent/SK12102002A3/sk unknown
- 2001-03-15 SI SI200130046T patent/SI1265873T1/xx unknown
- 2001-03-15 WO PCT/US2001/005811 patent/WO2001070706A2/en active IP Right Grant
- 2001-03-15 JP JP2001568916A patent/JP2003528087A/ja active Pending
- 2001-03-15 PT PT01920138T patent/PT1265873E/pt unknown
- 2001-03-15 CA CA002400000A patent/CA2400000A1/en not_active Abandoned
- 2001-03-15 AU AU2001247224A patent/AU2001247224A1/en not_active Abandoned
- 2001-03-15 EA EA200201002A patent/EA200201002A1/ru unknown
- 2001-03-15 EE EEP200200541A patent/EE200200541A/xx unknown
- 2001-03-15 US US09/808,836 patent/US6624160B2/en not_active Expired - Fee Related
- 2001-03-15 IL IL15178701A patent/IL151787A0/xx unknown
- 2001-03-15 MX MXPA02009251A patent/MXPA02009251A/es active IP Right Grant
- 2001-03-15 NZ NZ521524A patent/NZ521524A/en unknown
- 2001-03-15 DE DE60100999T patent/DE60100999T2/de not_active Expired - Fee Related
- 2001-03-15 AT AT01920138T patent/ATE252086T1/de not_active IP Right Cessation
- 2001-03-15 KR KR1020027012466A patent/KR20020081479A/ko not_active Application Discontinuation
- 2001-03-20 AR ARP010101303A patent/AR027978A1/es unknown
-
2002
- 2002-09-19 ZA ZA200207540A patent/ZA200207540B/en unknown
- 2002-09-20 NO NO20024502A patent/NO20024502L/no not_active Application Discontinuation
-
2003
- 2003-07-09 HK HK03104900.8A patent/HK1052694A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
PT1265873E (pt) | 2004-03-31 |
AU2001247224A1 (en) | 2001-10-03 |
CN1406228A (zh) | 2003-03-26 |
WO2001070706A2 (en) | 2001-09-27 |
US20020045619A1 (en) | 2002-04-18 |
ES2208581T3 (es) | 2004-06-16 |
EE200200541A (et) | 2004-04-15 |
CZ20023141A3 (cs) | 2003-02-12 |
NZ521524A (en) | 2004-04-30 |
HUP0300326A3 (en) | 2003-09-29 |
PL357443A1 (en) | 2004-07-26 |
SI1265873T1 (en) | 2004-02-29 |
DK1265873T3 (da) | 2004-02-16 |
ZA200207540B (en) | 2003-12-19 |
JP2003528087A (ja) | 2003-09-24 |
US6624160B2 (en) | 2003-09-23 |
EP1265873B1 (en) | 2003-10-15 |
HK1052694A1 (zh) | 2003-09-26 |
DE60100999D1 (en) | 2003-11-20 |
NO20024502L (no) | 2002-11-20 |
WO2001070706A3 (en) | 2002-05-10 |
IL151787A0 (en) | 2003-04-10 |
CA2400000A1 (en) | 2001-09-27 |
SK12102002A3 (sk) | 2003-03-04 |
KR20020081479A (ko) | 2002-10-26 |
ATE252086T1 (de) | 2003-11-15 |
DE60100999T2 (de) | 2004-09-02 |
AR027978A1 (es) | 2003-04-23 |
EA200201002A1 (ru) | 2003-02-27 |
MXPA02009251A (es) | 2004-04-05 |
NO20024502D0 (no) | 2002-09-20 |
BR0109487A (pt) | 2003-06-10 |
EP1265873A2 (en) | 2002-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60322267D1 (de) | Chinolinderivate als glucokinase liganden | |
HUP0500610A2 (hu) | Indazol-, benzotiazol- és benzoizotiazol-származékok, ezeket tartalmazó gyógyszerkészítmények és ezek alkalmazása | |
HUP0400837A2 (hu) | 2-feniltiazol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
HUP0202251A2 (hu) | Heterociklust tartalmazó bifenil aP2 inhibitorok és alkalmazásuk | |
DK0871606T3 (da) | Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet | |
JO2354B1 (en) | New derivatives of aromatic fluoroglycosides and drugs containing these compounds and their use | |
HUP0401729A2 (hu) | IV típusú foszfodiészteráz inhibitor hatású alkin-aril-naftiridin-4(1H)-on-származékok és ezeket tartalmazó gyógyszerkészítmények | |
HUP9901132A2 (hu) | 2-Alkilpirrolidinek | |
HUP0103319A2 (hu) | Készítmények HIV- és egyéb vírusfertőzések kezelésére és alkalmazásuk | |
NO20051047L (no) | Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater | |
HUP0401009A2 (hu) | 5-Hidroxitriptamin-6-ligandumokként alkalmazható 1-aril- vagy 1- alkil-szulfonilbenzazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0002353A2 (hu) | IV típusú foszfodiészteráz inhibitor hatású 1-cikloalkil-1,8-naftiridin-4-on-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
CY1110284T1 (el) | Παραγωγα της 2-αμινο-4-πυριδυλομεθυλο-θειαζολινης και η χρηση τους ως αναστολεις της επαγωγιμης συνθασης νο | |
DE69433984D1 (de) | Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d | |
HUP0103896A2 (hu) | Oxigéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
NO20024745D0 (no) | 2-hydroksymutilinkarbamat-derivater for antibakteriell anvendelse | |
ATE349448T1 (de) | Pyrazol-3,4-d-pyrimidinderivate und ihre verwendung bei der behandlung von h.pylori- infektionen | |
ATE182889T1 (de) | Bicyclische amidinderivate als no-synthetase inhibitoren | |
ATE399168T1 (de) | Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren | |
ATE218329T1 (de) | Anthracyclinon-derivate und ihre verwendung in amyloidose | |
ZA982137B (en) | Cycloalkylalkanecarboxamides and their preparation and use. | |
HUP0002159A2 (hu) | Eljárás peszticid hatóanyagok intermedierjeinek előállítására, az eljárásban alkalmazott új intermeierek és előállításuk | |
HUP0300326A2 (hu) | Vírusellenes hatású 4-oxo-1,4-dihidro-3-cinnolinkarboxamid-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
MY130750A (en) | Pyrimidine derivatives useful as selective cox-2 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |